The magnitude of the problem of chronic diseases (NCDs) in India is substantial and is growing

By EP News Bureau on November 7, 2014

Related Posts

Panel Discussion on ‘Building a pharma ecosystem: Science, Business and Ethics’

Dr Aravind Badiger, Technical Director, BDR Pharmaceuticals

Santosh Kakad, AGM – Sales and Marketing, Nitika Pharmaceutical Specialties

Ranjeet Singh, VP-Sales & Marketing, GD Waldner India

Dr Girish Achliya, Head-R&D, Gowrie Research

Dr Vasanthakumar Ramu, VP & Head R&D – Peptides & Complex APIs, Alembic Pharma

Stinita Dsouza, Application Specialist, Equitron Medica
Comments (0)
Add Comment